Polyneuron Pharmaceuticals AG

Swiss Biotech Association

Member

Polyneuron is a pharmaceutical company with a proprietary Antibody-Catch™ platform that enables the chemical design of injectable glycopolymers. These glycopolymers are designed to selectively eliminate autoantibodies in autoimmune disease patients, while leaving the immune system intact.

http://polyneuron.com/
+41 61 633 30 70
info@polyneuron.com
Dr. Ruben Herrendorff

Location

Hochbergerstrasse 60c, 4057 Basel, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2014
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

LATAM Pharma Innovative Ventures AG

LATAM Pharma offers made-to-measure solutions of immunization to public and private markets in Latin American and Caribbean countries.
6300 Zug

Member

Onward Therapeutics SA

We are a development stage oncology company, focusing on the identification of innovative technologies and the development of truly breakthrough medicines for the treatment of cancer.
1066 Épalinges

Member

NovaGo Therapeutics

NovaGo is focused on human antibody therapeutics targeting blood vessel & nerve growth. Our proprietary antibodies target Nogo-A, one of the most potent vascular & nerve growth inhibitors & have the potential to be a safe & effective treatment in ophthalmology and central nervous system indications.
8952 Schlieren

Member